Rebecca Ellwood, PA
Medical · Albany, NYNPI 1518100403
Payments from drug & device makers
Across 1,610 payments — averaging $350.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$211K
- Lilly USA, LLC$179K
- Sanofi-aventis U.S. LLC$114K
- Abbott$25K
- Insulet Corporation$20K
- Eli Lilly$6K
- plus $10K from 35 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 340 | $210,760 |
| Lilly USA, LLC | 560 | $179,214 |
| Sanofi-aventis U.S. LLC | 158 | $114,125 |
| Abbott | 99 | $24,534 |
| Insulet Corporation | 97 | $20,026 |
| Eli Lilly | 19 | $6,422 |
| Medtronic | 33 | $3,508 |
| Amgen(2 entities) | 60 | $943 |
| Mannkind Corporation | 34 | $558 |
| AstraZeneca(2 entities) | 33 | $531 |
| Dexcom, Inc. | 25 | $479 |
| Radius Health, Inc. | 18 | $434 |
| Bayer | 27 | $391 |
| AbbVie | 17 | $367 |
| Convatec Inc. | 1 | $240 |
| Sequel Med Tech, LLC | 1 | $214 |
| Ascendis Pharma Endocrinology Inc | 8 | $202 |
| Corcept Therapeutics | 11 | $199 |
| Boehringer Ingelheim | 11 | $173 |
| Pfizer | 7 | $168 |
| Tandem Diabetes Care, Inc. | 4 | $166 |
| IBSA Pharma Inc. | 7 | $135 |
| BETA Bionics, Inc. | 3 | $121 |
| Merck | 6 | $110 |
| Recordati_rare_diseases_inc. | 5 | $91 |
| Amneal Pharmaceuticals LLC | 5 | $90 |
| Ascensia Diabetes Care US Inc. | 2 | $59 |
| Chiesi USA, Inc. | 3 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Madrigal Pharmaceuticals | 1 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $31 |
| Rhythm Pharmaceuticals, Inc. | 1 | $28 |
| Tolmar, Inc. | 2 | $28 |
| BD | 2 | $27 |
| RGH Enterprises LLC | 1 | $19 |
| Bigfoot Biomedical Inc | 1 | $19 |
| Novartis | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| EUSA Pharma (US) LLC | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $11 |
How this compares
$564,598 in reported general payments places this provider in the 95th percentile of 2,395 medical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Albany
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
- Kimberly CossaroMassapequa$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.